Related Experiment Video
Updated: Aug 3, 2025

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
The Synergistic Antimicrobial Effect and Mechanism of Nisin and Oxacillin against Methicillin-Resistant
Jun Wang1,2, Xinxin Ma1, Jing Li1
1School of Public Health, Health Science Center, Xi'an Jiaotong University, Xi'an 710061, China.
Abstract:
Methicillin-resistant Staphylococcus aureus (MRSA) is responsible for skin and soft tissue infections with multi-resistance to many antibiotics. It is thus imperative to explore alternative antimicrobial treatments to ensure future treatment options. Nisin (NIS), an antibacterial peptide produced by Lactococcus lactis, was selected to combine with Oxacillin (OX), to evaluate the antimicrobial effect and potential mechanism against MRSA. The synergistic antimicrobial effect of OX and NIS was verified by Minimal Inhibitory Concentration (MIC) assays, checkerboard analysis, time-kill curve, biofilm producing ability, and mice skin infection model in vivo. For the potential synergistic antimicrobial mechanism, the microstructure and integrity change of MRSA cells were determined by Scanning and Transmission Electron Microscope (SEM and TEM), intracellular alkaline phosphatase activity and propidium iodide staining were assayed; And transcription of mecA, main gene of MRSA resistant to OX, were detected by qRT-PCR. The results showed NIS could restore the sensitivity of MRSA to OX and inhibit biofilm production; OX + NIS can make MRSA cell deform; NIS may recover OX sensitivity by inhibiting the transcription of mecA. In vivo, mice skin infection models indicate that OX + NIS can substantially alleviate MRSA infections. As a safe commercially available biological compound, NIS and the combination of antibiotics are worth developing as new anti-MRSA biomaterials.
Insights
Nisin (NIS) combined with Oxacillin (OX) effectively combats antibiotic-resistant MRSA infections. This combination restores antibiotic sensitivity and reduces bacterial damage in vivo.
Area of Science:
- Microbiology
- Pharmacology
- Biochemistry
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) presents a significant challenge due to multi-drug resistance.
- Novel therapeutic strategies are crucial for overcoming MRSA infections.
- Nisin (NIS), a bacteriocin, shows potential as an antimicrobial agent.
Purpose of the Study:
- To evaluate the synergistic antimicrobial effects of Nisin (NIS) and Oxacillin (OX) against MRSA.
- To elucidate the underlying mechanisms of the synergistic action.
- To assess the efficacy of the combination therapy in a murine skin infection model.
Main Methods:
- Minimal Inhibitory Concentration (MIC) assays, checkerboard analysis, and time-kill curves were employed.
- Biofilm formation, bacterial cell integrity (SEM/TEM), and intracellular activity were assessed.
- Gene transcription of mecA and in vivo efficacy in mice models were analyzed.
Main Results:
- Nisin (NIS) restored MRSA sensitivity to Oxacillin (OX) and inhibited biofilm production.
- The combination therapy (OX + NIS) induced MRSA cell deformation and reduced infection severity in vivo.
- NIS appeared to enhance OX sensitivity by downregulating mecA gene transcription.
Conclusions:
- The combination of Nisin (NIS) and Oxacillin (OX) exhibits synergistic antimicrobial activity against MRSA.
- This combination therapy offers a promising strategy for managing MRSA infections.
- Nisin's potential to restore antibiotic sensitivity warrants further development as an anti-MRSA biomaterial.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antimicrobial Effectiveness
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Development of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing

